GARDASIL

Product NDC
0006-4045
11-digit product format
000064045
Labeler code
0006
Product ID
0006-4045_32651aaa-4a24-4e44-8d7f-9960705a382f
Type
VACCINE
Nonproprietary name
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Labeler
Merck Sharp & Dohme LLC
Application
BLA125126
Marketing category
BLA
Marketing start
2006-06-08
Substance
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Active strength
40; 40; 20; 20 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Inactivated Human Papillomavirus Vaccine [EPC], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Papillomavirus Vaccines [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
GARDASIL
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN40 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN40 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0006-4045-00GARDASIL1 in 1 CARTONINJECTION, SUSPENSION132
0006-4045-01GARDASIL0.5 mL in 1 VIAL, SINGLE-DOSEINJECTION, SUSPENSION0.532
0006-4045-41GARDASIL10 in 1 CARTONINJECTION, SUSPENSION1032

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0006-4045-00ML - Milliliter0006-4045ed901cd8-6c1f-4d8e-b9af-58df37e333ee12013-02-13
0006-4045-01ML - Milliliter0006-404508590ade-52ba-471f-8a61-014f9a303d4e12013-02-13
0006-4045-41ML - Milliliter0006-4045b6f6293d-bed0-4776-98f6-e4e65b2e31e712013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGENACTIVE INGREDIENTZ845VHQ61PGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGENACTIVE INGREDIENT6LTE2DNX63GARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGENACTIVE INGREDIENTJ2D279PEM5GARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGENACTIVE INGREDIENT61746O90DYGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGENACTIVE MOIETYZ845VHQ61PGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGENACTIVE MOIETY6LTE2DNX63GARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGENACTIVE MOIETYJ2D279PEM5GARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGENACTIVE MOIETY61746O90DYGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
HISTIDINEINACTIVE INGREDIENT4QD397987EGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
SODIUM BORATEINACTIVE INGREDIENT91MBZ8H3QOGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23
WATERINACTIVE INGREDIENT059QF0KO0RGARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME CORP.]23

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0006-4045GARDASIL (HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT) INJECTION, SUSPENSION [MERCK SHARP & DOHME LLC]32Current NDC, Legacy NDC, 3 package rows20250416_30952400-0572-4431-9150-3a41affffb9a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
798278GARDASIL 0.5 ML Prefilled SyringePSN30952400-0572-4431-9150-3a41affffb9a32
798276human papillomavirus quadrivalent (types 6,11,16,18) vaccine, recombinant 0.5 mL Prefilled SyringePSN30952400-0572-4431-9150-3a41affffb9a32
7982780.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe [Gardasil]SBD30952400-0572-4431-9150-3a41affffb9a32
7982760.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled SyringeSCD30952400-0572-4431-9150-3a41affffb9a32
798278Gardasil, Human Papillomavirus Quadrivalent (Types 6,11,16,18) Vaccine, Recombinant 0.5 ML Prefilled SyringeSY30952400-0572-4431-9150-3a41affffb9a32
798276human papillomavirus quadrivalent (types 6,11,16,18) vaccine, recombinant 0.5 ML Prefilled SyringeSY30952400-0572-4431-9150-3a41affffb9a32

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0006-4045-00000064045001 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01) 2006-06-080000-00-00NoNoCurrent
0006-4045-01000064045010.5 mL in 1 VIAL, SINGLE-DOSE0.5 mlHistorical
0006-4045-410000640454110 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-41) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01) 2006-06-080000-00-00NoNoCurrent